Home/Filings/4/0001193125-25-297322
4//SEC Filing

D'Alessandro Danilo 4

Accession 0001193125-25-297322

CIK 0001285550other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:30 PM ET

Size

7.5 KB

Accession

0001193125-25-297322

Insider Transaction Report

Form 4
Period: 2025-11-21
D'Alessandro Danilo
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-21$8.10/sh+3,555$28,79669,923 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2025-11-213,55512,082 total
    Exercise: $8.10Exp: 2033-03-06Common Stock (3,555 underlying)
Footnotes (2)
  • [F1]Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
  • [F2]The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is March 6, 2023.

Documents

1 file

Issuer

ClearPoint Neuro, Inc.

CIK 0001285550

Entity typeother

Related Parties

1
  • filerCIK 0001825163

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:30 PM ET
Size
7.5 KB